Urinary Tract Infections: Epidemiology, Mechanisms of Infection, and Treatment
Abstract
Purpose: The main purpose of this study was to determine the mechanism of infection and the response of preferred antibiotic treatment during this study. Study: This study was conducted from February to March 2022. The approval for this randomized study was taken by the Ethical Committee of the concerned hospital. Written informed consent was signed by all participants. Total of 110 participants who reported problems with UTIs were part of this study. Levofloxacin 750 mg per day for five days and ciprofloxacin 500 mg twice per day for ten days were given to patients for treatment. Results: The total number of patients was 110, 65 (59.09%) males and 45 (40.90%) females having a mean age of 28 ± 5, urinary tract abnormalities were observed in 28 (25.45%) patients including obstruction in 16 (14.54%) patients, stone in 8 (7.27%)cases, the neurogenic bladder was in 4 (3.63%) patients and poly-microbial etiology was in 25 (22.72%) and catheterized patients was 35 (31.81%) in which chronic catheter cases were 15 (13.63%), intermittent catheter cases were 20 (18.18%), and Complicated UTIs was found in 22 (20.02%). 55 patients were treated with levofloxacin 51 (46.36%) reported a positive response and 51 (46.36%) were not cured with a p-value of 0.05. 55 patients were treated with ciprofloxacin of which 48 (43.63%) patients were cured and 7 (6.36%) were not cured with a p-value of 0.05. The number of patients treated with levofloxacin had a higher cured percentage 46.36% than those…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 110 participants or records.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.